RESUMO
OBJECTIVES: The purpose of this study was to determine hyolaryngeal kinematics during voicing in people with primary muscle tension dysphonia (pMTD) compared with healthy speakers, and to investigate the relationships between hyolaryngeal displacement and self-perceived vocal function. METHODS: Twenty-six participants, 13 with pMTD and 13 healthy speakers, were assessed using sonography during sustained vowel phonation and rest. Displacement of the hyoid bone and thyroid cartilage was measured from still frames extracted from ultrasound video recordings, with measures normalized to reflect change from rest during voicing for each participant. Vocal function was determined for all participants through self-perceived speaking effort and the Voice Handicap Index-10. RESULTS: Normalized displacement of the hyoid bone and thyroid cartilage was significantly greater during voicing for participants with pMTD than for the healthy speakers. Weak-to-moderate, nonsignificant relationships between hyoid displacement and vocal function measures were evidenced, whereas moderate-to-strong, significant relationships were found for thyroid displacement and vocal function measures. CONCLUSIONS: Displacement of the hyoid and elevation of the larynx during phonation appear to be prominent features of pMTD that differentiate the disorder from healthy phonatory kinematics. Ultrasound imaging provides a sensitive, reliable, noninvasive, and feasible method for objectively determining hyolaryngeal kinematics and may be useful for differential diagnosis and determination of treatment outcomes in pMTD.
RESUMO
OBJECTIVES: The purpose of this study was to describe the theoretical and procedural framework of a novel intervention, Respiratory Lung Volume Training (RLVT), and to implement a standardized treatment taxonomy to operationalize the RLVT treatment paradigm. STUDY DESIGN: This study involved a prospective design with a consensus treatment classification process. METHODS: The RLVT paradigm was developed based on biomechanical constructs governing the interactions of the respiratory and phonatory systems in voice production and principles of motor learning theory. In RLVT, higher levels of lung volume (LV) during speech are trained using multiple speech breathing strategies while providing real-time visual biofeedback with superimposed guidelines for desired LV initiation and termination levels. For people with primary muscle tension dysphonia (MTD), RLVT can capitalize on nonmuscular respiratory forces to increase efficiency of voice production with reduced speaking effort. To define and operationalize the treatment components of RLVT, six investigators with training in RLVT used the Rehabilitation Treatment Specification System to delineate the treatment targets, mechanisms of action, ingredients and dosing through a multistage, consensus decision-making process. RESULTS: The finalized taxonomy for RLVT included four treatment targets, with three addressing the area of Respiratory Function and one addressing Somatosensory Function. For each treatment target, three categories of ingredients were defined: (1) provide opportunities to practice breathing during voicing/speech, (2) provide feedback, and (3) provide volition ingredients. Within each ingredient category, three to seven specific ingredients were ultimately defined to further operationalize RLVT. CONCLUSIONS: The RLVT paradigm is a theoretically driven approach for optimizing speech breathing patterns to increase efficient voice production in people with primary MTD. By applying a standardized, systematic treatment taxonomy system to specify the components of RLVT, future researchers and clinicians can implement RLVT with improved fidelity and consistency to optimize treatment outcomes.